The Role of Brachytherapy Alone and in Combined Treatment of Esophageal Cancer—A Review
Every year, over 600,000 new cases of esophageal cancer are registered worldwide. Treatment depends on the stage of the disease. In the early stages, surgical treatment is the basis (T1–T2 lesion < 3 cm, N0M0), while in more advanced stages, surgical treatment is preceded by radiochemotherapy or...
Main Authors: | Paweł Cisek, Aleksander Strąk, Paulina Stachyra-Strawa, Andrzej Majdan, Ludmiła Grzybowska-Szatkowska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/14/7/2840 |
Similar Items
-
Radioimmunotherapy: future prospects
from the perspective of brachytherapy
by: Maximilian Fleischmann, et al.
Published: (2021-08-01) -
Optimum Radiation Fractionation Schedule in Advanced Cancer Cervix; A Study from Low Resource North Indian Cancer Center
by: Taruna Singh, et al.
Published: (2022-02-01) -
High‐dose‐rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome
by: Iosif Strouthos, et al.
Published: (2022-01-01) -
External beam boost versus interstitial high-dose-rate brachytherapy boost in the adjuvant radiotherapy following breast-conserving therapy in early-stage breast cancer: a dosimetric comparison
by: Martje Marie Terheyden, et al.
Published: (2016-08-01) -
TREATMENT OUTCOMES OF EXTERNAL BEAM RADIOTHERAPY COMBINED WITH HIGH-DOSE-RATE BRACHYTHERAPY IN PATIENTS WITH ESOPHAGEAL CANCER
by: A. A. Lozhkov, et al.
Published: (2017-03-01)